Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced today that its exVive3D™ Human Liver Model has been selected as a finalist in the Diagnostics & Research Tools category for the 2014 Most Innovative New Product Awards, sponsored by CONNECT. CONNECT, a regional program that catalyzes the creation of innovative technology and life sciences products in San Diego County, continues its twenty-seven year tradition of honoring San Diego's leaders of innovation and groundbreaking new products with the annual award.
Organovo's exVive3D™ Liver bioprinted human tissue models are living, functional 3D human liver tissue constructs consisting of primary human hepatocytes, stellate, and endothelial cell types which are found in native human liver. The exVive3D™ Livers are created using Organovo's proprietary 3D bioprinting technology that results in functional living tissues containing precise and reproducible architecture. The tissues can remain fully functional and stable for at least 40 days. This model will initially be made available through Organovo's contract research testing to improve the predictive value for liver tissue specific toxicity or ADMET marker assessment in later stage preclinical drug discovery programs.
"For 27 years, CONNECT has been hosting the Most Innovative Products (MIP) awards and each year the entrants just keep getting better – this is one of the most competitive fields we've seen for MIP yet," said Greg McKee, CEO of CONNECT. "Annually, through the MIP awards CONNECT proudly presents to the community the innovations and ground-breaking products being developed in San Diego."
